000 | 01031 a2200313 4500 | ||
---|---|---|---|
005 | 20250512050957.0 | ||
264 | 0 | _c19880714 | |
008 | 198807s 0 0 ger d | ||
022 | _a0300-8622 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBayerdörffer, E | |
245 | 0 | 0 |
_a[Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease]. _h[electronic resource] |
260 |
_bLeber, Magen, Darm _cApr 1988 |
||
300 |
_a104-13 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAminosalicylic Acids _xadverse effects |
650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMesalamine |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aSuppositories |
700 | 1 | _aBock, H | |
773 | 0 |
_tLeber, Magen, Darm _gvol. 18 _gno. 2 _gp. 104-13 |
|
999 |
_c3379985 _d3379985 |